Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed by the Epworth Sleepiness Scale (ESS), despite being treated 74% of treated narcolepsy type 1 patients…#bccci #depression #cns #unmetneeds #narcolepsy #narcolepsynetwork #hypersomnia #crescendo #nt1 #eds
Source: Reuters: Health - Category: Consumer Health News Source Type: news